MUKTA GUPTA
Bristol-Myers Squibb Holdings Ireland Unlimited Company – Appellant
Versus
BDR Pharmaceuticals International Pvt. Ltd. – Respondent
JUDGMENT :
MUKTA GUPTA, J.
I.A. 803/2020 (u/O XXXIX R 1 & 2 CPC)
1. The present suit and application came up before this Court on 21st January, 2020 when learned counsel for the defendants urged that he had additional material to oppose the ad-interim injunction de-hors what was argued in the earlier round of litigations between the plaintiffs and third parties wherein this Court had granted ad-interim injunction against which appeals are pending before the Hon’ble Division Bench.
2. Part arguments were addressed on behalf of the parties on 21st January, 2020 whereafter the hearing was kept at end of the board on 22nd January, 2020 and learned counsel for the defendant handed over nine documents including a revocation petition filed in December, 2019 on which he would base his arguments to the Court and learned counsel for the plaintiffs. In the post-lunch session on 22nd January, 2020 learned counsel for the defendant was on his legs in the Hon’ble Supreme Court when this Court directed learned counsel for the plaintiff to address arguments on the 9 documents relied upon by the defendant. Thereafter, arguments were heard and concluded on behalf of learned counsel for the defendant on
Login now and unlock free premium legal research
Login to SupremeToday AI and access free legal analysis, AI highlights, and smart tools.
Login
now!
India’s Legal research and Law Firm App, Download now!
Copyright © 2023 Vikas Info Solution Pvt Ltd. All Rights Reserved.